Vida Ventures Advisors, LLC
CIK 1831423 · View on SEC EDGAR ↗
- Portfolio value
- $29.4M
- Positions
- 2
- As of
- Sept. 30, 2025 Data as of Q3 2025
#8,858 of 9,443 by 13F value · top 93.8%
Portfolio value QoQ: +84.5% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q3 2025: 0.0% Est. buys $0 · sells $0
Median holding: 1.5 quarters Tracked Q4 2024–Q3 2025 · 33.3% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 0
- Closed
- 1
On this page
Sector breakdown
Healthcare
100.0%
Full portfolio 2 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| KYTX Kyverna Therapeutics, Inc. - Common Stock | $27,143,544 | 92.41% | 4,523,924 | $13,255,097 | |||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $2,229,722 | 7.59% | 1,798,163 | $197,798 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.